{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:25:17Z","timestamp":1763400317599,"version":"3.44.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"New Frontiers in Research Fund","award":["NFRFE-2019-00927"],"award-info":[{"award-number":["NFRFE-2019-00927"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Industry-funded research poses a threat to the validity of scientific inference on carcinogenic hazards. Scientists require tools to better identify and characterize industry sponsored research across bodies of evidence to reduce the possible influence of industry bias in evidence synthesis reviews. We applied a novel large language model (LLM)-based tool named InfluenceMapper to demonstrate and evaluate its performance in identifying relationships to industry in research on the carcinogenicity of benzene, cobalt, and aspartame.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>All epidemiological, animal cancer, and mechanistic studies included in systematic reviews on the carcinogenicity of the three agents by the <jats:italic>IARC Monographs<\/jats:italic> programme. Selected agents were recently evaluated by the <jats:italic>Monographs<\/jats:italic> and are of commercial interest by major industries. InfluenceMapper extracted disclosed entities in study publications and classified up to 40 possible disclosed relationship types between each entity and the study and between each entity and author. A human classified entities as \u2018industry or industry-funded\u2019 and assessed relationships with industry for potential conflicts of interest. Positive predictive values described the extent of true positive relationships identified by InfluenceMapper compared to human assessment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Analyses included 2,046 studies for all three agents. We identified 320 disclosed industry or industry-funded entities from InfluenceMapper output that were involved in 770 distinct study-entity and author-entity relationships. For each agent, between 4 and 8% of studies disclosed funding by industry and 1\u20134% of studies had at least one author who disclosed receiving industry funding directly. Industry trade associations for all three agents funded 22 studies published in 16 journals over a 37-year span. Aside from funding, the most prevalent disclosed relationships with industry were receiving data, holding employment, paid consulting, and providing expert testimony. Positive predictive values were excellent (\u2265\u200998%) for study-entity relationships but declined for relationships with individual authors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>LLM-based tools can significantly expedite and bolster the detection of disclosed conflicts of interest from industry sponsored research in cancer prevention. Possible use cases include facilitating the assessment of bias from industry studies in evidence synthesis reviews and alerting scientists to the influence of industry on scientific inference. Persistent challenges in ascertaining conflicts of interest underscore the urgent need for standardized, transparent, and enforceable disclosures in biomedical journals.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12940-025-01223-1","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:41:13Z","timestamp":1758739273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A large language model-based tool for identifying relationships to industry in research on the carcinogenicity of benzene, cobalt, and aspartame"],"prefix":"10.1186","volume":"24","author":[{"given":"Nathan L.","family":"DeBono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Amar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hardy","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Schubauer-Berigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Ruths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas B.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"1223_CR1","unstructured":"World Health Organization. Commercial determinants of health. 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/commercial-determinants-of-health. Accessed 10 June 2025."},{"issue":"1","key":"1223_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2105\/AJPH.2011.300292","volume":"102","author":"AM Brandt","year":"2012","unstructured":"Brandt AM. Inventing conflicts of interest: A history of tobacco industry tactics. Am J Public Health. 2012;102(1):63\u201371. https:\/\/doi.org\/10.2105\/AJPH.2011.300292.","journal-title":"Am J Public Health"},{"issue":"2","key":"1223_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/003335490512000215","volume":"120","author":"LA Bero","year":"2005","unstructured":"Bero LA. Tobacco industry manipulation of research. Public Health Rep. 2005;120(2):200\u20138. https:\/\/doi.org\/10.1177\/003335490512000215.","journal-title":"Public Health Rep"},{"key":"1223_CR4","doi-asserted-by":"publisher","unstructured":"Tweedale G. Magic mineral to killer dust: Turner & Newall and the asbestos hazard. Oxford University Press; 2001. https:\/\/doi.org\/10.1093\/acprof:oso\/9780199243990.001.0001.","DOI":"10.1093\/acprof:oso\/9780199243990.001.0001"},{"issue":"10","key":"1223_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ajim.20435","volume":"50","author":"D Rosner","year":"2007","unstructured":"Rosner D, Markowitz G. The politics of lead toxicology and the devastating consequences for children. Am J Ind Med. 2007;50(10):740\u201356. https:\/\/doi.org\/10.1002\/ajim.20435.","journal-title":"Am J Ind Med"},{"issue":"3","key":"1223_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1179\/oeh.2006.12.3.268","volume":"12","author":"PF Infante","year":"2006","unstructured":"Infante PF. The past suppression of industry knowledge of the toxicity of benzene to humans and potential bias in future benzene research. Int J Occup Environ Health. 2006;12(3):268\u201372. https:\/\/doi.org\/10.1179\/oeh.2006.12.3.268.","journal-title":"Int J Occup Environ Health"},{"key":"1223_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-069X-5-5","volume":"5","author":"D Michaels","year":"2006","unstructured":"Michaels D, Monforton C, Lurie P. Selected science: an industry campaign to undermine an OSHA hexavalent chromium standard. Environ Health. 2006;5:5. https:\/\/doi.org\/10.1186\/1476-069X-5-5.","journal-title":"Environ Health"},{"key":"1223_CR8","unstructured":"Gillam C. The Monsanto papers: deadly secrets, corporate corruption, and one man\u2019s search for justice. Island; 2021."},{"key":"1223_CR9","doi-asserted-by":"publisher","unstructured":"Sass JB, Needleman HL. Industry testing of toxic pesticides on human subjects concluded no effect, despite the evidence. Environ Health Perspect. 2004;112(3):A150-151. https:\/\/doi.org\/10.1289\/ehp.112-1241878. (author reply A151-152; discussion A152-156).","DOI":"10.1289\/ehp.112-1241878"},{"key":"1223_CR10","unstructured":"David Michaels. Doubt is their product: how industry\u2019s assault on science threatens your health. Oxford University Press; 2008."},{"key":"1223_CR11","unstructured":"David Michaels. The triumph of doubt: dark money and the science of deception. Oxford University Press; 2020."},{"issue":"3","key":"1223_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ajim.22549","volume":"59","author":"L Rollin","year":"2016","unstructured":"Rollin L, Griffon N, Darmoni SJ, Gehanno JF. Influence of author\u2019s affiliation and funding sources on the results of cohort studies on occupational cancer. Am J Ind Med. 2016;59(3):221\u20136. https:\/\/doi.org\/10.1002\/ajim.22549.","journal-title":"Am J Ind Med"},{"issue":"2","key":"1223_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40572-017-0139-y","volume":"4","author":"EM Wells","year":"2017","unstructured":"Wells EM. Evidence regarding the impact of conflicts of interest on environmental and occupational health research. Curr Environ Health Rep. 2017;4(2):109\u201318. https:\/\/doi.org\/10.1007\/s40572-017-0139-y.","journal-title":"Curr Environ Health Rep"},{"issue":"1","key":"1223_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1057\/s41271-017-0096-6","volume":"39","author":"C Velicer","year":"2017","unstructured":"Velicer C, Helen GS, Glantz SA. Tobacco papers and tobacco industry ties in regulatory toxicology and Pharmacology. J Public Health Policy. 2017;39(1):34. https:\/\/doi.org\/10.1057\/s41271-017-0096-6.","journal-title":"J Public Health Policy"},{"issue":"3","key":"1223_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/JOM.0000000000000671","volume":"58","author":"L Friedman","year":"2016","unstructured":"Friedman L, Friedman M. Financial conflicts of interest and study results in environmental and occupational health research. J Occup Environ Med. 2016;58(3):238\u201347. https:\/\/doi.org\/10.1097\/JOM.0000000000000671.","journal-title":"J Occup Environ Med"},{"issue":"4","key":"1223_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.289.4.454","volume":"289","author":"JE Bekelman","year":"2003","unstructured":"Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454\u201365. https:\/\/doi.org\/10.1001\/jama.289.4.454.","journal-title":"JAMA"},{"issue":"9","key":"1223_CR17","doi-asserted-by":"publisher","first-page":"e0162198","DOI":"10.1371\/journal.pone.0162198","volume":"11","author":"D Mandrioli","year":"2016","unstructured":"Mandrioli D, Kearns CE, Bero LA. Relationship between research outcomes and risk of bias, study sponsorship, and author financial conflicts of interest in reviews of the effects of artificially sweetened beverages on weight outcomes: A systematic review of reviews. PLoS ONE. 2016;11(9):e0162198. https:\/\/doi.org\/10.1371\/journal.pone.0162198.","journal-title":"PLoS ONE"},{"key":"1223_CR18","unstructured":"University of California, San Francisco Library. Industry Documents Library. 2025. https:\/\/www.industrydocuments.ucsf.edu\/. Accessed 6 May 2025."},{"key":"1223_CR19","unstructured":"Merlin Chowkwanyun G, Markowitz, Rosner D. Toxic Docs: Version 1.0. 2018. https:\/\/www.toxicdocs.org. Accessed 6 May 2025."},{"issue":"7","key":"1223_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2105\/AJPH.2019.305126","volume":"109","author":"D Michaels","year":"2019","unstructured":"Michaels D. Reimagining our system for public health protection. Am J Public Health. 2019;109(7):975\u20136. https:\/\/doi.org\/10.2105\/AJPH.2019.305126.","journal-title":"Am J Public Health"},{"key":"1223_CR21","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.5: considering bias and conflicts of interest among the included studies. 2024. https:\/\/training.cochrane.org\/handbook\/current\/chapter-07. Accessed 10 June 2025."},{"issue":"1","key":"1223_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12940-021-00771-6","volume":"20","author":"CL Soskolne","year":"2021","unstructured":"Soskolne CL, Kramer S, Ramos-Bonilla JP, et al. Toolkit for detecting misused epidemiological methods. Environ Health. 2021;20(1):90. https:\/\/doi.org\/10.1186\/s12940-021-00771-6.","journal-title":"Environ Health"},{"issue":"4","key":"1223_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1057\/s41271-021-00318-6","volume":"42","author":"G Reed","year":"2021","unstructured":"Reed G, Hendlin Y, Desikan A, MacKinney T, Berman E, Goldman GT. The disinformation playbook: how industry manipulates the science-policy process-and how to restore scientific integrity. J Public Health Policy. 2021;42(4):622\u201334. https:\/\/doi.org\/10.1057\/s41271-021-00318-6.","journal-title":"J Public Health Policy"},{"issue":"1","key":"1223_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12940-021-00723-0","volume":"20","author":"RF Goldberg","year":"2021","unstructured":"Goldberg RF, Vandenberg LN. The science of spin: targeted strategies to manufacture doubt with detrimental effects on environmental and public health. Environ Health. 2021;20(1):33. https:\/\/doi.org\/10.1186\/s12940-021-00723-0.","journal-title":"Environ Health"},{"issue":"11","key":"1223_CR25","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2105\/AJPH.2018.304715","volume":"108","author":"M Daube","year":"2018","unstructured":"Daube M. Shining a light on industry research funding. Am J Public Health. 2018;108(11):1441\u20132. https:\/\/doi.org\/10.2105\/AJPH.2018.304715.","journal-title":"Am J Public Health"},{"key":"1223_CR26","doi-asserted-by":"publisher","unstructured":"Lieberum JL, T\u00f6ws M, Metzendorf MI, et al. Large Language models for conducting systematic reviews: on the rise, but not yet ready for use\u2014a scoping review. J Clin Epidemiol. 2025;181. https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111746.","DOI":"10.1016\/j.jclinepi.2025.111746"},{"issue":"5","key":"1223_CR27","doi-asserted-by":"publisher","first-page":"e2412687","DOI":"10.1001\/jamanetworkopen.2024.12687","volume":"7","author":"H Lai","year":"2024","unstructured":"Lai H, Ge L, Sun M, et al. Assessing the risk of bias in randomized clinical trials with large Language models. JAMA Netw Open. 2024;7(5):e2412687. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.12687.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1223_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmjebm-2024-112990","volume":"30","author":"J Barsby","year":"2025","unstructured":"Barsby J, Hume S, Lemmey HA, Cutteridge J, Lee R, Bera KD. Pilot study on large Language models for risk-of-bias assessments in systematic reviews: A(I) new type of bias? BMJ EBM. 2025;30(1):71\u20134. https:\/\/doi.org\/10.1136\/bmjebm-2024-112990.","journal-title":"BMJ EBM"},{"issue":"6","key":"1223_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/bmjebm-2023-112597","volume":"29","author":"B Hasan","year":"2024","unstructured":"Hasan B, Saadi S, Rajjoub NS, et al. Integrating large Language models in systematic reviews: a framework and case study using ROBINS-I for risk of bias assessment. BMJ EBM. 2024;29(6):394\u20138. https:\/\/doi.org\/10.1136\/bmjebm-2023-112597.","journal-title":"BMJ EBM"},{"issue":"2","key":"1223_CR30","doi-asserted-by":"publisher","first-page":"e2411962122","DOI":"10.1073\/pnas.2411962122","volume":"122","author":"FM Delgado-Chaves","year":"2025","unstructured":"Delgado-Chaves FM, Jennings MJ, Atalaia A, et al. Transforming literature screening: the emerging role of large Language models in systematic reviews. Proc Natl Acad Sci USA. 2025;122(2):e2411962122. https:\/\/doi.org\/10.1073\/pnas.2411962122.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1223_CR31","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jrsm.1715","volume":"15","author":"Q Khraisha","year":"2024","unstructured":"Khraisha Q, Put S, Kappenberg J, Warraitch A, Hadfield K. Can large Language models replace humans in systematic reviews? Evaluating GPT-4\u2019s efficacy in screening and extracting data from peer-reviewed and grey literature in multiple Languages. Res Synthesis Methods. 2024;15(4):616\u201326. https:\/\/doi.org\/10.1002\/jrsm.1715.","journal-title":"Res Synthesis Methods"},{"key":"1223_CR32","unstructured":"Hardy H, Ruths D, King NB. Who controlled the evidence? Question answering for disclosure information extraction. In: Mortazavi BJ, Sarker T, Beam A, Ho JC, editors. Proceedings of the Conference on Health, Inference, and Learning. Vol 209. Proceedings of Machine Learning Research. PMLR; 2023. pp. 340\u20139. https:\/\/proceedings.mlr.press\/v209\/hardy23a.html."},{"key":"1223_CR33","unstructured":"InfluenceMapper. 2025. https:\/\/github.com\/networkdynamics\/influencemapper. Accessed 10 June 2025."},{"issue":"12","key":"1223_CR34","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/S1470-2045(17)30832-X","volume":"18","author":"D Loomis","year":"2017","unstructured":"Loomis D, Guyton KZ, Grosse Y, et al. Carcinogenicity of benzene. Lancet Oncol. 2017;18(12):1574\u20135. 2045(17)30832-X.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1223_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1470-2045(22)00219-4","volume":"23","author":"MR Karagas","year":"2022","unstructured":"Karagas MR, Wang A, Dorman DC, et al. Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy. Lancet Oncol. 2022;23(5):577\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(22)00219-4.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1223_CR36","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1470-2045(23)00341-8","volume":"24","author":"E Riboli","year":"2023","unstructured":"Riboli E, Beland FA, Lachenmeier DW, et al. Carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lancet Oncol. 2023;24(8):848\u201350. https:\/\/doi.org\/10.1016\/S1470-2045(23)00341-8.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1223_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jnci\/djz169","volume":"112","author":"JM Samet","year":"2019","unstructured":"Samet JM, Chiu WA, Cogliano V, et al. The IARC monographs: updated procedures for modern and transparent evidence synthesis in cancer hazard identification. JNCI: J Natl Cancer Inst. 2019;112(1):30\u20137. https:\/\/doi.org\/10.1093\/jnci\/djz169.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"1223_CR38","unstructured":"IARC Monographs Programme. 131 - M1 - Cobalt metal (without tungsten carbide) and cobalt (II) compounds. 2021. https:\/\/hawcproject.iarc.who.int\/assessment\/678\/. Accessed 6 Mar 2025."},{"key":"1223_CR39","unstructured":"IARC Monographs Programme. 134 - M1 - Aspartame. 2023. https:\/\/hawcproject.iarc.who.int\/assessment\/680\/. Accessed 6 Mar 2025."},{"key":"1223_CR40","unstructured":"Lopez PGROBID. 2025. https:\/\/github.com\/kermitt2\/grobid. Accessed 10 June 2025."},{"issue":"12","key":"1223_CR41","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1001\/jamainternmed.2021.4584","volume":"181","author":"I Hameed","year":"2021","unstructured":"Hameed I, Mori M, Ahmed A, et al. Financial associations between authors of commentaries on randomized clinical trials of invasive cardiovascular interventions and trial sponsors. JAMA Intern Med. 2021;181(12):1662\u20135. https:\/\/doi.org\/10.1001\/jamainternmed.2021.4584.","journal-title":"JAMA Intern Med"},{"issue":"14","key":"1223_CR42","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1289\/ehp.6200","volume":"111","author":"S Wing","year":"2003","unstructured":"Wing S. Objectivity and ethics in environmental health science. Environ Health Perspect. 2003;111(14):1809\u201318.","journal-title":"Environ Health Perspect"},{"issue":"4","key":"1223_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1179\/1077352513Z.00000000090","volume":"19","author":"RL Melnick","year":"2013","unstructured":"Melnick RL, Ward JM, Huff J. War on carcinogens: industry disputes human relevance of chemicals causing cancer in laboratory animals based on unproven hypotheses, using kidney tumors as an example. Int J Occup Environ Health. 2013;19(4):255\u201360. https:\/\/doi.org\/10.1179\/1077352513Z.00000000090.","journal-title":"Int J Occup Environ Health"},{"issue":"7","key":"1223_CR44","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2105\/AJPH.2019.305131","volume":"109","author":"JM Samet","year":"2019","unstructured":"Samet JM. Expert review under attack: glyphosate, talc, and cancer. Am J Public Health. 2019;109(7):976\u20138. https:\/\/doi.org\/10.2105\/AJPH.2019.305131.","journal-title":"Am J Public Health"},{"issue":"4","key":"1223_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1515\/reveh-2019-0004","volume":"34","author":"RF Goldberg","year":"2019","unstructured":"Goldberg RF, Vandenberg LN. Distract, delay, disrupt: examples of manufactured doubt from five industries. Rev Environ Health. 2019;34(4):349\u201363. https:\/\/doi.org\/10.1515\/reveh-2019-0004.","journal-title":"Rev Environ Health"},{"issue":"3\u20134","key":"1223_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JRS-180028","volume":"29","author":"LB McHenry","year":"2018","unstructured":"McHenry LB. The Monsanto papers: poisoning the scientific well. Int J Risk Saf Med. 2018;29(3\u20134):193\u2013205. https:\/\/doi.org\/10.3233\/JRS-180028.","journal-title":"Int J Risk Saf Med"},{"issue":"6","key":"1223_CR47","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/EDE.0000000000001091","volume":"30","author":"TH Tran","year":"2019","unstructured":"Tran TH, Steffen JE, Clancy KM, Bird T, Egilman DS. Talc, asbestos, and epidemiology: corporate influence and scientific incognizance. Epidemiology. 2019;30(6):783. https:\/\/doi.org\/10.1097\/EDE.0000000000001091.","journal-title":"Epidemiology"},{"issue":"2","key":"1223_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/1048291121996645","volume":"31","author":"T Bird","year":"2021","unstructured":"Bird T, Steffen JE, Tran TH, Egilman DS. A review of the Talc industry\u2019s influence on federal regulation and scientific standards for asbestos in Talc. New Solut. 2021;31(2):152\u201369. https:\/\/doi.org\/10.1177\/1048291121996645.","journal-title":"New Solut"},{"issue":"1","key":"1223_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12940-018-0392-z","volume":"17","author":"PJ Landrigan","year":"2018","unstructured":"Landrigan PJ, Belpoggi F. The need for independent research on the health effects of glyphosate-based herbicides. Environ Health. 2018;17(1):51. https:\/\/doi.org\/10.1186\/s12940-018-0392-z.","journal-title":"Environ Health"},{"issue":"1","key":"1223_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12940-019-0527-x","volume":"18","author":"X Baur","year":"2019","unstructured":"Baur X, Soskolne CL, Bero LA. How can the integrity of occupational and environmental health research be maintained in the presence of conflicting interests? Environ Health. 2019;18(1):93. https:\/\/doi.org\/10.1186\/s12940-019-0527-x.","journal-title":"Environ Health"},{"issue":"48","key":"1223_CR51","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.1021\/acs.est.3c04213","volume":"57","author":"A Sch\u00e4ffer","year":"2023","unstructured":"Sch\u00e4ffer A, Groh KJ, Sigmund G, et al. Conflicts of interest in the assessment of chemicals, waste, and pollution. Environ Sci Technol. 2023;57(48):19066\u201377. https:\/\/doi.org\/10.1021\/acs.est.3c04213.","journal-title":"Environ Sci Technol"},{"issue":"1","key":"1223_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1289\/ehp.9149","volume":"115","author":"A Huss","year":"2007","unstructured":"Huss A, Egger M, Hug K, Huwiler-M\u00fcntener K, R\u00f6\u00f6sli M. Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies. Environ Health Perspect. 2007;115(1):1\u20134. https:\/\/doi.org\/10.1289\/ehp.9149.","journal-title":"Environ Health Perspect"},{"issue":"8","key":"1223_CR53","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jech-2015-207005","volume":"70","author":"CJ Portier","year":"2016","unstructured":"Portier CJ, Armstrong BK, Baguley BC, et al. Differences in the carcinogenic evaluation of glyphosate between the international agency for research on cancer (IARC) and the European food safety authority (EFSA). J Epidemiol Community Health. 2016;70(8):741\u20135. https:\/\/doi.org\/10.1136\/jech-2015-207005.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"1223_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12940-022-00926-z","volume":"21","author":"N Chartres","year":"2022","unstructured":"Chartres N, Sass JB, Gee D, et al. Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions. Environ Health. 2022;21(1):123. https:\/\/doi.org\/10.1186\/s12940-022-00926-z.","journal-title":"Environ Health"},{"key":"1223_CR55","unstructured":"Center for Truth in Science. FAQ Seeking integrity in the pursuit of scientific knowledge. 2025. https:\/\/truthinscience.org\/about\/faq\/. Accessed 6 May 2025."},{"key":"1223_CR56","doi-asserted-by":"publisher","first-page":"q1153","DOI":"10.1136\/bmj.q1153","volume":"385","author":"I Berg","year":"2024","unstructured":"Berg I, de van den, Jeu M, Boytchev H. Tobacco funded research: how even journals with bans find it hard to stem the tide of publications. BMJ. 2024;385:q1153. https:\/\/doi.org\/10.1136\/bmj.q1153.","journal-title":"BMJ"},{"key":"1223_CR57","doi-asserted-by":"publisher","unstructured":"Thomas S, Hennessy M, Frazer K, et al. Conflicts of interest in public health research and publications. 2025. https:\/\/doi.org\/10.1093\/heapro\/daaf009. Accessed 21 Feb 2025.","DOI":"10.1093\/heapro\/daaf009"},{"key":"1223_CR58","unstructured":"Berrington de Gonz\u00e1lez A, Richardson DB, Schubauer-Berigan MK. Statistical methods in cancer research volume V: bias assessment in case\u2013control and cohort studies for hazard identification. Chapter 1. IARC Scientific Publication No. 171; 2024. https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Iarc-Scientific-Publications\/Statistical-Methods-In-Cancer-Research-Volume-V-Bias-Assessment-In-Case%E2%80%93Control-And-Cohort-Studies-For-Hazard-Identification-2024."},{"issue":"4","key":"1223_CR59","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1179\/oeh.2003.9.4.386","volume":"9","author":"O Axelson","year":"2003","unstructured":"Axelson O, Balbus JM, Cohen G, et al. Re: regulatory toxicology and Pharmacology. Int J Occup Environ Health. 2003;9(4):386\u20139. https:\/\/doi.org\/10.1179\/oeh.2003.9.4.386. author reply.","journal-title":"Int J Occup Environ Health"},{"issue":"2","key":"1223_CR60","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1179\/oeh.2005.11.2.202","volume":"11","author":"DS Egilman","year":"2005","unstructured":"Egilman DS. Suppression bias at the journal of occupational and environmental medicine. Int J Occup Environ Health. 2005;11(2):202\u20134. https:\/\/doi.org\/10.1179\/oeh.2005.11.2.202.","journal-title":"Int J Occup Environ Health"},{"issue":"7","key":"1223_CR61","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/00043764-200607000-00019","volume":"48","author":"P Brandt-Rauf","year":"2006","unstructured":"Brandt-Rauf P. Editorial retraction. Cancer mortality in a Chinese population exposed to hexavalent chromium in water. J Occup Environ Med. 2006;48(7):749. https:\/\/doi.org\/10.1097\/00043764-200607000-00019.","journal-title":"J Occup Environ Med"}],"container-title":["Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12940-025-01223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12940-025-01223-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12940-025-01223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:41:17Z","timestamp":1758739277000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehjournal.biomedcentral.com\/articles\/10.1186\/s12940-025-01223-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1186\/s12940-025-01223-1","relation":{},"ISSN":["1476-069X"],"issn-type":[{"value":"1476-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Derek Ruths holds a consulting position with Petro AI, a company that provides software services to clients in the oil and gas industry. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}